AI-based morphologic model for prediction of individual patient response to immune checkpoint inhibitors for bladder cancer.

MLA

Nair, Monica, et al. “AI-Based Morphologic Model for Prediction of Individual Patient Response to Immune Checkpoint Inhibitors for Bladder Cancer.” Journal of Clinical Oncology, vol. 42, Feb. 2024, p. 686. EBSCOhost, https://doi.org/10.1200/JCO.2024.42.4_suppl.686.

APA

Nair, M., Liao, R., Jain, P., Xie, C., Muhammad, H., Huang, W., Basu, H. S., Wilding, G., Roy, R., Diaz-Montero, C. M., Hwang, T. H., Dawsey, S., Nguyen, J., Klein, E. A., Gupta, S., & Mian, O. Y. (2024). AI-based morphologic model for prediction of individual patient response to immune checkpoint inhibitors for bladder cancer. Journal of Clinical Oncology, 42, 686. https://doi.org/10.1200/JCO.2024.42.4_suppl.686

Chicago

Nair, Monica, Ross Liao, Parag Jain, Chensu Xie, Hassan Muhammad, Wei Huang, Hirak S Basu, et al. 2024. “AI-Based Morphologic Model for Prediction of Individual Patient Response to Immune Checkpoint Inhibitors for Bladder Cancer.” Journal of Clinical Oncology 42 (February): 686. doi:10.1200/JCO.2024.42.4_suppl.686.